EcoDrugPlus

Progesterone Receptor

Ensembl ID : ENSDLAG00005025654
Gene Symbol: PGR
1 Cross references
193 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSDLAG00005014387
Gene Symbol: PTGER1A
1 Cross references
171 Possible Orthologues:

Prostaglandin E Receptor 1b (Subtype Ep1)

Ensembl ID : ENSDLAG00005017951
Gene Symbol: PTGER1B
1 Cross references
163 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSDLAG00005021780
Gene Symbol: PTGER2A
1 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 2b (Subtype Ep2)

Ensembl ID : ENSDLAG00005020304
Gene Symbol: PTGER2B
1 Cross references
172 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSDLAG00005014008
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSDLAG00005018113
Gene Symbol: PTGER4A
1 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSDLAG00005028637
Gene Symbol: PTGER4B
1 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSDLAG00005006201
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSDLAG00005025759
Gene Symbol: PTGS2B
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSDLAG00005016689
Gene Symbol: PSMA3
1 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 6a

Ensembl ID : ENSDLAG00005023268
Gene Symbol: PSMA6A
1 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).